Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy
Clinical trial NCT02300545 · COMPLETED
Trial details
- NCT number
- NCT02300545
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-08
- Primary completion
- 2019-05-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.